Literature DB >> 23432078

Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy.

Viveka Sundelin Wahlsten1, Ihsan Sarman.   

Abstract

AIM: To study the neurobehavioural development and somatic growth of children at preschool-age born to opioid-addicted mothers given opiate maintenance treatment (OMT) with buprenorphine during pregnancy.
METHODS: Twenty-eight children, whose 21 opiate-addicted mothers were treated with OMT during pregnancy and accepted participation to the study, went through a battery of neurobehavioural tests (WPPSI-R, McCarthy, BROWN and SDQ). Twenty-five children fulfilled the tests at an age of 5-6 years.
RESULTS: The children showed evidence of serious visual motor and attention problems in the field of performance (WPPSI-R scales) and major problems in the field of motor skills and memory abilities (McCarthy Scales). The results of behavioural tests also showed significantly elevated levels of hyperactivity, impulsivity and attention problems on the attention deficit hyperactivity disorder (ADHD) scale in BROWN and in SDQ tests estimated by the teachers, while the parents estimated no problems for their children. Regarding the outcomes, there were no significant differences in terms of neonatal abstinence syndrome, gender or socio-economic factors. The somatic growth of the children corresponded to the mean values of the normal population in weight, length and head circumference at birth and at preschool-age, respectively.
CONCLUSION: Children to opiate-addicted mothers with buprenorphine maintenance treatment during pregnancy constitute a risk population, which should be recognized before start of the school. Whether the effects are associated with buprenorphine exposition during foetal life or not are discussed and need further investigation. ©2013 Foundation Acta Paediatrica. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23432078     DOI: 10.1111/apa.12210

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  28 in total

Review 1.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

2.  Prenatally buprenorphine-exposed children: health to 3 years of age.

Authors:  Kaisa Kivistö; Sarimari Tupola; Satu Kivitie-Kallio
Journal:  Eur J Pediatr       Date:  2015-05-24       Impact factor: 3.183

Review 3.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

4.  Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children.

Authors:  Eric Rubenstein; Jessica C Young; Lisa A Croen; Carolyn DiGuiseppi; Nicole F Dowling; Li-Ching Lee; Laura Schieve; Lisa D Wiggins; Julie Daniels
Journal:  J Autism Dev Disord       Date:  2019-01

5.  Effects of opioid use in pregnancy on pediatric development and behaviour in children older than age 2: Systematic review.

Authors:  Stephanie Welton; Brittany Blakelock; Sharen Madden; Len Kelly
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

6.  Comparison of Neonatal Abstinence Syndrome Manifestations in Preterm Versus Term Opioid-Exposed Infants.

Authors:  Elizabeth Allocco; Marjorie Melker; Florencia Rojas-Miguez; Caitlin Bradley; Kristen A Hahn; Elisha M Wachman
Journal:  Adv Neonatal Care       Date:  2016-10       Impact factor: 1.968

7.  Sedatives for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

Review 8.  Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.

Authors:  Yaa Abu; Sabita Roy
Journal:  Exp Neurol       Date:  2021-01-29       Impact factor: 5.330

Review 9.  Prenatal Opioid Exposure and ADHD Childhood Symptoms: A Meta-Analysis.

Authors:  Ashlyn N Schwartz; Lucia M Reyes; Laurie L Meschke; Kristina W Kintziger
Journal:  Children (Basel)       Date:  2021-02-04

Review 10.  Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.

Authors:  Andrew E Weller; Richard C Crist; Benjamin C Reiner; Glenn A Doyle; Wade H Berrettini
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.